DOI: 10.1055/s-00023610

Drug Research

Issue 11 · Volume 66 · November 2016 DOI: 10.1055/s-006-32784

Review

  • 562
    van Niel, J. C. G.; Schneider, J.; Tzschentke, T. M.:

    Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists – Preclinical and Clinical Evidence

  • 571
    Majidinia, M.; Alizadeh, E.; Yousefi, B.; Akbarzadeh, M.; Zarghami, N.:

    Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment

  • 580
    Panahi, Y.; Mohammadhosseini, M.; Abadi, A. J. N.; Akbarzadeh, A.; Mellatyar, H.:

    An Update on Biomedical Application of Nanotechnology for Alzheimer’s Disease Diagnosis and Therapy

    • Original Article

  • 587
    Balaji, K.; Bhatt, P.; Jha, A.:

    Expeditious Synthesis, Antimicrobial and Antimalarial Activities of Novel Heterocycles Bearing Imidazole-oxadiazole Based Hybrid Pharmacophores

    Supporting Information (PDF)
  • 592
    Najibi, A.; Heidari, R.; Zarifi, J.; Jamshidzadeh, A.; Firoozabadi, N.; Niknahad, H.:

    Evaluating the Role of Drug Metabolism and Reactive Intermediates in Trazodone-Induced Cytotoxicity toward Freshly-Isolated Rat Hepatocytes

  • 597
    Alipour, M.; Fekrmandi, F.; Onsori, S.; Tabrizian, P.; Jafari, M. R.:

    The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice

  • 603
    Kusunoki, M.; Natsume, Y.; Sato, D.; Tsutsui, H.; Miyata, T.; Tsutsumi, K.; Suga, T.; Oshida, Y.:

    Luseogliflozin, A Sodium Glucose Co-transporter 2 Inhibitor, Alleviates Hepatic Impairment in Japanese Patients with Type 2 Diabetes

  • 607
    Rump, A.; Stricklin, D.; Lamkowski, A.; Eder, S.; Abend, M.; Port, M.:

    The Impact of Time on Decorporation Efficacy After a “Dirty Bomb” Attack Studied by Simulation

    • Short Communication

  • 614
    Zormann, A.; Blum, J.; Suenderhauf, C.; Vogel, M.; Walter, A.:

    Agomelatine and Transient Elevation of Creatine Phosphokinase